市場調査レポート

商品コード

1566212

ボツリヌス毒素の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Botulinum Toxin Market Size, Share, Growth Analysis, By Product (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology Clinics), By Region - Industry Forecast 2024-2031

出版日: 2024年10月06日 | 発行: SkyQuest

| ページ情報: 英文 165 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 800,088円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 935,952円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,071,816円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のボツリヌス毒素の市場規模は、2022年に100億1,000万米ドルとなり、予測期間（2024年～2031年）のCAGRは9.83%で、2023年の111億2,000万米ドルから、2031年までには235億4,000万米ドルに成長する見通しです。

世界のボツリヌス毒素（BNT）市場は、現在の用途にとどまらず治療用途の拡大を目指した研究開発の進展に加え、美容的かつ非侵襲的な施術に対する需要の増加により、大きな成長が見込まれています。7つの抗原型からなる注目すべき製品には、BNT-Aの限られた品揃えとBNT-Bの単一製品があり、市場の多様化とイノベーションの可能性が強調されています。新製品発売の動向は、患者の負担軽減の改善や、ボツリヌス注射の保険適用を含む償還政策の進化と相まって、この成長をさらに後押ししています。美容治療に対する消費者の関心が顕著に高まっていることから、米国のボツリヌス毒素市場は、今後の予測期間において持続的なCAGRを記録すると予想されます。企業が研究開発に戦略的に投資することで、製品ポートフォリオが強化され、美容と治療の両領域でボツリヌス毒素がより広く受け入れられるようになると思われます。全体として、これらの要因が重なることで、ボツリヌス毒素市場の前途は有望であり、ヘルスケア業界におけるダイナミックなセグメントとして位置づけられます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Ipsen Group
Allergan Inc.
Medy-Tox, Inc.
Metabiologics
Merz Pharma
Supernus Pharmaceutical
Evolus
Galderma
Lanzhou Institute of Biological Products
Revance Therapeutics
Hugel
Suneva Medical
Daewoong Pharmaceutical
Mylan
Teijin Pharma
Eisai
Prollenium Medical

Product Code: SQMIG35I2220

Global Botulinum Toxin Market size was valued at USD 10.01 billion in 2022 and is poised to grow from USD 11.12 billion in 2023 to USD 23.54 billion by 2031, growing at a CAGR of 9.83% during the forecast period (2024-2031).

The global botulinum toxin (BNT) market is poised for significant growth, driven by increasing demand for cosmetic and non-invasive procedures, alongside advancements in research and development aimed at expanding therapeutic applications beyond its current uses. Comprising seven antigenic forms, notable products include a limited array of BNT-A and a singular BNT-B offering, underscoring the potential for market diversification and innovation. The trend towards new product launches, coupled with improving patient affordability and evolving reimbursement policies that now include coverage for botulinum injections, further propels this growth. With a notable increase in consumer interest in aesthetic treatments, the U.S. market for botulinum toxin is expected to experience a sustainable compound annual growth rate (CAGR) in the forthcoming forecast period. As companies invest strategically in R&D, this will enhance the product portfolio and encourage broader acceptance of botulinum toxin in both cosmetic and therapeutic domains. Overall, the confluence of these factors suggests a promising trajectory ahead for the botulinum toxin market, positioning it as a dynamic segment within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botulinum Toxin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botulinum Toxin Market Segmental Analysis

Global Botulinum Toxin Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Type A (Botox, Dysport, Xeomin, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Cosmetic Centers and Medspas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Botulinum Toxin Market

The increasing demand for minimally invasive cosmetic procedures is a significant market driver for the global botulinum toxin market. As more individuals seek non-surgical options to achieve youthful appearances with minimal recovery time, botulinum toxin treatments have become increasingly popular for reducing wrinkles and fine lines. This trend is further fueled by a growing awareness of the benefits of aesthetic procedures, enhanced by social media influence and celebrity endorsements. Additionally, advancements in technology and product formulations have improved the effectiveness and safety of botulinum toxin therapies, thereby expanding their application in both cosmetic and therapeutic settings, propelling market growth.

Restraints in the Global Botulinum Toxin Market

The global botulinum toxin market may face significant restraints due to the potential side effects associated with its use. Adverse reactions, including muscle weakness, allergic reactions, and localized pain, can deter patients from seeking treatments, thus impacting market growth. Additionally, the perception of safety risks can influence healthcare professionals' recommendations, further complicating patient acceptance. Regulatory scrutiny surrounding the approval and marketing of botulinum toxin products may also pose challenges, as companies must navigate stringent guidelines while addressing concerns related to side effects. The cumulative effect of these factors could inhibit the expansion of the market and limit its overall potential.

Market Trends of the Global Botulinum Toxin Market

The global botulinum toxin market is witnessing significant growth, driven predominantly by cosmetic procedures favored by women, who constitute a remarkable 92% of all treatments. With a rising number of individuals over 40 prioritizing their physical appearance, especially in developed nations, the demand for aesthetics enhancements continues to surge. This trend is emphasized by the remarkable statistic of over 2.5 million women aged 40-54 undergoing botulinum toxin procedures in 2020 alone. As societal norms around beauty evolve, this market trend indicates robust prospects for botulinum toxin, with a sustained focus on anti-aging solutions likely to propel its expansion well into the future.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Regulatory Landscape

Botulinum Toxin Market, By Product

Market Overview
Type A
- Botox
- Dysport
- Xeomin
- Others
Type B

Botulinum Toxin Market, By Application

Market Overview
Therapeutic
- Chronic Migraine
- Overactive Bladder
- Cervical Dystonia
- Spasticity
- Others
Aesthetic
- Glabellar Lines
- Crow's Feet
- Forehead Lines
- Others

Botulinum Toxin Market, By End User

Market Overview
Hospitals
Dermatology Clinics
Cosmetic Centers and Medspas

Botulinum Toxin Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Ipsen Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medy-Tox, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Supernus Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Institute of Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daewoong Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teijin Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eisai
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prollenium Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ボツリヌス毒素の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Botulinum Toxin Market Size, Share, Growth Analysis, By Product (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology Clinics), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

ボツリヌス毒素市場：製品別

ボツリヌス毒素市場：用途別

ボツリヌス毒素市場：エンドユーザー別

ボツリヌス毒素市場規模：地域別